Articles
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.
Journal:
J Clin Lipidol
First published: May 31, 2023 DOI: 10.1016/j.jacl.2023.05.098
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
ConfirmBallantyne CM, Ditmarsch M, Kastelein JJ, et al.
J Clin Lipidol
First published: May 31, 2023 DOI: 10.1016/j.jacl.2023.05.098